261 related articles for article (PubMed ID: 28234437)
1. Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data.
Mizushima J; Uchida H; Tada M; Suzuki T; Mimura M; Nio S
J Clin Psychiatry; 2017 Feb; 78(2):e146-e151. PubMed ID: 28234437
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
[TBL] [Abstract][Full Text] [Related]
3. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME
N Engl J Med; 2007 Apr; 356(17):1711-22. PubMed ID: 17392295
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant dose and treatment response in bipolar depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data.
Tada M; Uchida H; Mizushima J; Suzuki T; Mimura M; Nio S
J Psychiatr Res; 2015 Sep; 68():151-6. PubMed ID: 26228414
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
7. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
McIntyre RS; Cucchiaro J; Pikalov A; Kroger H; Loebel A
J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
[TBL] [Abstract][Full Text] [Related]
8. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
9. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
Goldberg JF; Perlis RH; Ghaemi SN; Calabrese JR; Bowden CL; Wisniewski S; Miklowitz DJ; Sachs GS; Thase ME
Am J Psychiatry; 2007 Sep; 164(9):1348-55. PubMed ID: 17728419
[TBL] [Abstract][Full Text] [Related]
12. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
[TBL] [Abstract][Full Text] [Related]
13. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
15. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
Ghaemi SN
Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
[TBL] [Abstract][Full Text] [Related]
16. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Perlis RH; Ostacher MJ; Patel JK; Marangell LB; Zhang H; Wisniewski SR; Ketter TA; Miklowitz DJ; Otto MW; Gyulai L; Reilly-Harrington NA; Nierenberg AA; Sachs GS; Thase ME
Am J Psychiatry; 2006 Feb; 163(2):217-24. PubMed ID: 16449474
[TBL] [Abstract][Full Text] [Related]
17. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
Altshuler LL; Suppes T; Black DO; Nolen WA; Leverich G; Keck PE; Frye MA; Kupka R; McElroy SL; Grunze H; Kitchen CM; Post R
Am J Psychiatry; 2006 Feb; 163(2):313-5. PubMed ID: 16449487
[TBL] [Abstract][Full Text] [Related]
18. Does recent mania affect response to antidepressants in bipolar disorder? A re-analysis of STEP-BD data.
Mousavi Z; Johnson S; Li D
J Affect Disord; 2018 Aug; 236():136-139. PubMed ID: 29734096
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
[TBL] [Abstract][Full Text] [Related]
20. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
